Tchaikapharma Highquality Medicines, a flagship company on the Bulgarian pharma market, started trading shares on the Bulgarian Stock Exchange (BSE) on 21 May 2015. On today’s date exactly 6 years ago, the initial offering price per share was BGN 3.59, and on 21 May 2021 – BGN 14.10. This represents a growth of 292.757% over […]
SOFIA (Bulgaria), February 23 (SeeNews) – Bulgarian drug maker Tchaikapharma High Quality Medicines [BUL:7TH] said that its shareholders have approved its plan to borrow up to 14 million euro ($17.2 million) in order to finance the construction of a new production plant just outside Sofia. The proposal was supported by all shareholders present at […]
At the beginning of February, one share of the company costs BGN 13.80, which means that the market capitalization of the pharmaceutical equals 1.13 billion leva. Read the full article here in Bulgarian.
We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficult time, we could assure that the Bulgarian population had access to reliable and affordable medical prevention and early COVID-19 treatment with hydroxychloroquine. At the […]
Patients with rheumatic disease are less likely to suffer from coronavirus, especially those taking hydroxychloroquine. That is why their therapy should not be interrupted during the pandemic, says rheumatologist Prof. Rasho Rashkov and clarifies that he and his colleagues have many years of experience in the treatment with hydroxychloroquine, as well as treatment of some […]